Home LiteratureArticle Details
PMID: 8411338 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.

Journal of virology ·Vol. 67 ·No. 11 ·1993-11-00 ·Pages 6365-78

Purcell DF, Martin MA

Abstract

Multiple RNA splicing sites exist within human immunodeficiency virus type 1 (HIV-1) genomic RNA, and these sites enable the synthesis of many mRNAs for each of several viral proteins. We evaluated the biological significance of the alternatively spliced mRNA species during productive HIV-1 infections of peripheral blood lymphocytes and human T-cell lines to determine the potential role of alternative RNA splicing in the regulation of HIV-1 replication and infection. First, we used a semiquantitative polymerase chain reaction of cDNAs that were radiolabeled for gel analysis to determine the relative abundance of the diverse array of alternatively spliced HIV-1 mRNAs. The predominant rev, tat, vpr, and env RNAs contained a minimum of noncoding sequence, but the predominant nef mRNAs were incompletely spliced and invariably included noncoding exons. Second, the effect of altered RNA processing was measured following mutagenesis of the major 5' splice donor and several cryptic, constitutive, and competing 3' splice acceptor motifs of HIV-1NL4-3. Mutations that ablated constitutive splice sites led to the activation of new cryptic sites; some of these preserved biological function. Mutations that ablated competing splice acceptor sites caused marked alterations in the pool of virus-derived mRNAs and, in some instances, in virus infectivity and/or the profile of virus proteins. The redundant RNA splicing signals in the HIV-1 genome and alternatively spliced mRNAs provides a mechanism for regulating the relative proportions of HIV-1 proteins and, in some cases, viral infectivity.

Related Genes
MeSH Terms
Alternative Splicing Base Sequence HIV Envelope Protein gp120/genetics HIV-1/genetics Molecular Sequence Data Oligodeoxyribonucleotides/chemistry Polymerase Chain Reaction Protein Biosynthesis RNA, Messenger/genetics RNA, Viral/genetics Retroviridae Proteins/genetics Virus Replication
Chemicals
HIV Envelope Protein gp120 Oligodeoxyribonucleotides RNA, Messenger RNA, Viral Retroviridae Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Purcell D F
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
Martin M A
References (56)
56 references, click to expand
  1. Human immunodeficiency virus rev protein recognizes a target sequence in rev-responsive element RNA within the context of RNA secondary structure.
    J Virol. 1990 Dec;64(12):5966-75 PMID: 2243382
  2. Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7787-91 PMID: 2217212
  3. Human growth hormone DNA sequence and mRNA structure: possible alternative splicing.
    Nucleic Acids Res. 1981 Aug 11;9(15):3719-30 PMID: 6269091
  4. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.
    Nature. 1985 Feb 7-13;313(6002):450-8 PMID: 2982104
  5. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.
    Science. 1985 Jul 5;229(4708):74-7 PMID: 2990041
  6. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.
    Cell. 1986 Mar 28;44(6):941-7 PMID: 2420471
  7. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  8. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.
    Cell. 1986 Sep 12;46(6):807-17 PMID: 3638988
  9. Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1986 Dec;83(24):9734-8 PMID: 3025848
  10. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein.
    Cell. 1987 Feb 27;48(4):691-701 PMID: 3643816
  11. The HIV 'A' (sor) gene product is essential for virus infectivity.
    Nature. 1987 Aug 20-26;328(6132):728-30 PMID: 2441266
  12. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens.
    J Exp Med. 1987 Nov 1;166(5):1548-66 PMID: 2824653
  13. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.
    J Virol. 1988 Jan;62(1):139-47 PMID: 3257102
  14. A novel gene of HIV-1, vpu, and its 16-kilodalton product.
    Science. 1988 Sep 2;241(4870):1221-3 PMID: 3261888
  15. Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor.
    Proc Natl Acad Sci U S A. 1988 Dec;85(23):9224-8 PMID: 3194421
  16. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region.
    J Virol. 1989 Mar;63(3):1265-74 PMID: 2783738
  17. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.
    Nature. 1989 Mar 16;338(6212):254-7 PMID: 2784194
  18. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.
    Proc Natl Acad Sci U S A. 1989 Mar;86(5):1495-9 PMID: 2784208
  19. Regulation of human immunodeficiency virus env expression by the rev gene product.
    J Virol. 1989 May;63(5):1959-66 PMID: 2704072
  20. Regulation of tissue-specific alternative splicing: exon-specific cis-elements govern the splicing of leukocyte common antigen pre-mRNA.
    EMBO J. 1989 Mar;8(3):787-96 PMID: 2524382
  21. The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization.
    Cell. 1989 Jun 30;57(7):1155-65 PMID: 2736624
  22. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.
    J Virol. 1989 Sep;63(9):3708-13 PMID: 2760980
  23. Regulation by HIV Rev depends upon recognition of splice sites.
    Cell. 1989 Dec 1;59(5):789-95 PMID: 2686839
  24. Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9549-53 PMID: 2687884
  25. Functional analysis of CAR, the target sequence for the Rev protein of HIV-1.
    Science. 1989 Dec 22;246(4937):1625-9 PMID: 2688093
  26. Control of retroviral RNA splicing through maintenance of suboptimal processing signals.
    Mol Cell Biol. 1990 Feb;10(2):696-704 PMID: 2153921
  27. A general method for rapid site-directed mutagenesis using the polymerase chain reaction.
    Gene. 1990 Nov 30;96(1):125-8 PMID: 2265750
  28. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.
    Genes Dev. 1991 May;5(5):808-19 PMID: 1827422
  29. Importance of the nef gene for maintenance of high virus loads and for development of AIDS.
    Cell. 1991 May 17;65(4):651-62 PMID: 2032289
  30. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes.
    Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):5011-5 PMID: 1711215
  31. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing.
    Virology. 1991 Sep;184(1):319-29 PMID: 1871974
  32. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev.
    Cell. 1991 Oct 4;67(1):169-78 PMID: 1913815
  33. Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein.
    Virology. 1991 Nov;185(1):258-70 PMID: 1926777
  34. Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs.
    Mol Cell Biol. 1992 Jan;12(1):207-19 PMID: 1729599
  35. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs.
    Mol Cell Biol. 1992 Mar;12(3):1375-86 PMID: 1545819
  36. Biochemical mechanisms of constitutive and regulated pre-mRNA splicing.
    Annu Rev Cell Biol. 1991;7:559-99 PMID: 1839712
  37. Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing.
    Eur J Immunol. 1992 Jun;22(6):1513-8 PMID: 1601037
  38. Identification of two novel human immunodeficiency virus type 1 splice acceptor sites in infected T cell lines.
    J Gen Virol. 1992 Jul;73 ( Pt 7):1825-8 PMID: 1629704
  39. The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates.
    Virology. 1992 Aug;189(2):618-28 PMID: 1641982
  40. Interactions of small nuclear RNA's with precursor messenger RNA during in vitro splicing.
    Science. 1992 Sep 25;257(5078):1918-25 PMID: 1411506
  41. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.
    J Virol. 1992 Dec;66(12):7328-35 PMID: 1433521
  42. Alternative mRNA splicing.
    Annu Rev Cell Biol. 1992;8:133-55 PMID: 1335742
  43. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus.
    J Virol. 1993 Feb;67(2):902-12 PMID: 8380472
  44. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.
    Nature. 1993 Mar 25;362(6418):355-8 PMID: 8455722
  45. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.
    Nature. 1993 Mar 25;362(6418):359-62 PMID: 8096068
  46. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
    Science. 1993 Mar 19;259(5102):1749-54 PMID: 8096089
  47. HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region.
    Cell. 1990 Feb 23;60(4):685-93 PMID: 1689218
  48. Secondary structure is the major determinant for interaction of HIV rev protein with RNA.
    Science. 1990 Feb 16;247(4944):845-8 PMID: 2406903
  49. A tripartite HIV-1 tat-env-rev fusion protein.
    EMBO J. 1990 Mar;9(3):965-70 PMID: 2178928
  50. A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.
    J Virol. 1990 Jun;64(6):2505-18 PMID: 2186172
  51. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.
    J Virol. 1990 Jun;64(6):2519-29 PMID: 2335812
  52. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.
    J Virol. 1990 Jul;64(7):3391-8 PMID: 2191150
  53. Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells.
    J Virol. 1990 Sep;64(9):4093-8 PMID: 2384914
  54. Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1.
    J Virol. 1990 Sep;64(9):4585-8 PMID: 2384924
  55. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs.
    J Virol. 1990 Nov;64(11):5448-56 PMID: 2214021
  56. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.
    Cell. 1978 Jul;14(3):725-31 PMID: 210957
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1993-11-00
Pages
6365-78
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC238071
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]